Total planned funding: $699,659,838
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $168,699,829 |
| Uganda | $115,933,448 |
| Kenya | $90,685,585 |
| Zambia | $71,143,642 |
| Mozambique | $49,674,459 |
| Tanzania | $39,113,237 |
| Côte d'Ivoire | $36,448,892 |
| South Africa | $32,431,549 |
| Zimbabwe | $25,314,348 |
| Rwanda | $24,642,892 |
| Vietnam | $14,425,620 |
| Haiti | $10,011,133 |
| Botswana | $7,498,858 |
| Ethiopia | $7,000,000 |
| Namibia | $1,879,596 |
| Democratic Republic of the Congo | $1,483,576 |
| Guyana | $1,231,690 |
| Burundi | $1,208,202 |
| Eswatini | $659,961 |
| Malawi | $138,000 |
| Angola | $34,000 |
| Cambodia | $1,321 |
Organizational Types
| Private Contractor | $554,758,955 |
| NGO | $74,746,951 |
| Unknown | $19,963,651 |
| FBO | $16,125,666 |
| Implementing Agency | $14,376,825 |
| Host Country Government Agency | $12,258,312 |
| University | $4,124,263 |
| Own Agency | $2,231,589 |
| Parastatal | $1,073,626 |
| Other USG Agency | $0 |
Program Areas
| Treatment | $699,659,838 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $699,659,838 |